top of page

WOUND

Cutting-edge diagnostics is pivotal for delivering superior healthcare. Molecular testing, specifically designed for wound infections emerges as a transformative tool offering a multitude of clinical advantages.

 

Let’s explore how the integration of molecular wound testing can elevate the standard of care in a multitude of healthcare settings including long term care, medical offices and specialty care facilities.

Wound.jpeg

WHY CHOOSE MOLECULAR WOUND TESTING?

Comprehensive Infection Management: Elderly patients, and those with mobility issues often face a spectrum of health challenges, with wound infections being prevalent concerns. Molecular wound testing ensures a comprehensive approach to infection management. Healthcare providers can swiftly and accurately identify the causative pathogens, streamlining the treatment process.

 

Rapid Diagnosis for Timely Interventions: Time is of the essence in healthcare, and rapid diagnosis is critical for effective interventions. Molecular wound testing provides quick and accurate results, enabling healthcare professionals to initiate targeted treatments promptly. This timely approach is particularly crucial in preventing the escalation of infections and ensuring the well-being of patients.

 

Tailored Treatment Plans for Optimal Outcomes: The diversity of infections demands personalized treatment approaches. Molecular testing, with its ability to provide detailed insights into the specific pathogens involved in wounds infections allows healthcare providers to craft tailored treatment plans. This precision enhances the efficacy of interventions, contributing to improved patient outcomes and satisfaction.

Proactive Infection Control: In a communal setting like a nursing home, preventing the spread of infections is a top priority. Molecular wound testing aids in early detection, empowering caregivers to implement isolation measures and targeted treatments promptly. This proactive approach not only contains infections but also contributes to maintaining a healthier environment for all residents.

 

Minimizing Antibiotic Resistance Risks: Molecular wound testing supports a more targeted and judicious use of antibiotics. By identifying the specific pathogens causing infections, healthcare providers can prescribe antibiotics more selectively, minimizing the risk of antibiotic resistance. This approach aligns with the global effort to promote responsible antibiotic use.

 

27 Pathogens Tested

Acinetobacter baumannii

Candida albicans

Candida glabrata

Citrobacter freundii

Clostridium perfringens

Corynebacterium striatum

Enterobacter aerogenes

Morganella morganii

Proteus mirabilis

Proteus vulgaris

Pseudomonas aeruginosa

Salmonella enterica

Serratia marcescens

Staphylococcus aureus

Enterobacter cloacae

Enterococcus faecalis

Enterococcus faecium

Escherichia coli

Finegoldia magna

Klebsiella oxytoca

Klebsiella pneumoniae

Staphylococcus epidermidis

Staphylococcus haemolyticus

Staphylococcus saprophyticus

Streptococcus agalactiae

Streptococcus pneumoniae

Streptococcus pyogenes

tablet,DNA,meds.jpeg

Phi Life Sciences Molecular Wound Testing Includes:

 

• Collection kit including collection swab with transport tube and biohazard bag.

• Comprehensive collection instructions.

• Return shipping or sample pick up.

• On line result reporting 24-48 hours after sample receipt.

• Easy to interpret patient-focused report which allows providers

to effectively address pathogens while maintaining responsible antibiotic stewardship.

bottom of page